Optometry - Journal of the American Optometric Association
Volume 75, Issue 4 , Pages 245-250, April 2004

Pseudoexfoliation syndrome and pseudoexfoliative glaucoma

  • Joseph Sowka, O.D.

      Affiliations

    • Corresponding Author InformationCorrespondence address: Nova Southeastern University, College of Optometry, 3200 South University Drive, Ft. Lauderdale, Florida 33328.

Nova Southeastern University, College of Optometry, Ft. Lauderdale, Florida

Article Outline

Background

Pseudoexfoliative glaucoma (PXG) is a common secondary glaucoma that occurs when pigment and abnormal basement membrane material from anterior segment anatomical structures deposit in the trabecular meshwork. This anomaly arises from the predisposing condition, pseudoexfoliation syndrome (PXE). Complications are common, making this one of the most difficult glaucomas to manage.

Purpose

The literature is reviewed in order to facilitate understanding of this condition.

Key Words: Basement membrane, fibrillopathy, pigment, pseudoexfoliation, secondary glaucoma

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Karp CL, Fazio JR, Culbertson WW, et al. True exfoliation of the lens capsule. Arch Ophthalmol. 1999;117:1078–1080
  2. Dvorak-Theobald G. Pseudoexfoliation of the lens capsule: relation to “true” exfoliation of the lens capsule as reported in the literature and role in its production of glaucoma capsule–cuticulare. Am Ophthalmol. 1954;37:1–12
  3. Layden WE, Shaffer RN. Exfoliation syndrome. Trans Am Ophthalmol Soc. 1973;71:128–151
  4. Vesti E, Kivela T. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:345–368
  5. Forsius H. Exfoliation syndrome in various ethnic populations. Acta Ophthalmol Suppl. 1988;184:71–85
  6. Summanen P, Tonjum AM. Exfoliation syndrome among the Saudis. Acta Ophthalmol Suppl. 1988;184:107–111
  7. Aasved H. The geographical distribution of fibrillopathia epitheliocapsularis (so-called senile exfoliation or pseudoexfoliation of the anterior lens capsule). Acta Ophthalmol (Copenh). 1969;47:792–810
  8. Kozobolis VP, Papatzanaki M, Vlachonikolis IG, et al. Epidemiology of pseudoexfoliation in the island of Crete (Greece). Acta Ophthalmol Scand. 1997;75:726–729
  9. Hiller R, Sperduto RD, Krueger DE. Pseudoexfoliation, intraocular pressure and senile changes in a population based survey. Arch Ophthalmol. 1982;100:1080–1082
  10. Ball SF. Exfoliation syndrome prevalence in the glaucoma population of South Louisiana. Acta Ophthalmol Suppl. 1988;184:93–98
  11. Crittendon JJ, Shields MB. Exfoliation syndrome in the Southeastern United States II. Characteristics of patient population and clinical course. Acta Ophthalmol Suppl. 1988;184:103–106
  12. Krause U, Tarkkanen A. Cataract and Pseudoexfoliation. A clinicopathological study. Acta Ophthalmol (Copenh). 1978;56:329–334
  13. Konstas AG, Ritch R, Bufidis T, et al. Exfoliation syndrome in a 17-year-old girl. Arch Ophthalmol. 1997;115:1063–1067
  14. Krause U, Alanko HI, Karna J, et al. Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol Suppl. 1988;184:120–122
  15. Hirvela H, Tuulonen A, Laatikainen L. Intraocular pressure and the prevalence of glaucoma in elderly people in Finland: a population based study. Int Ophthalmol. 1995;18:299–307
  16. Orr AC, Robitaille JM, Price , et al. Exfoliation syndrome: clinical and genetic features. Ophthalmic Genet. 2001;22:171–185
  17. Damji KF, Bains HS, Amjadi K, et al. Familial occurrence of pseudoexfoliation in Canada. Can J Ophthalmol. 1999;34:257–265
  18. Allingham RR, Loftsdottir M, Gottfredsdottir MS, et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol. 2001;85:702–707
  19. Damji KF, Bains HS, Stefansson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and non-genetic factors and a new observation. Ophthalmic Genet. 1998;19:175–185
  20. Mudumbai R, Liebmann JM, Ritch R. Combined exfoliation and pigment dispersion: an overlap syndrome. Trans Am Ophthalmol Soc. 1999;97:297–321
  21. Amari F, Umihira J, Nohara M, et al. Electron microscopic immunohistochemistry of ocular and extraocular pseudoexfoliative material. Exp Eye Res. 1997;65:51–56
  22. Kubota T, Schlotzer-Schrehardt U, Inomata H, et al. Immunoelectron microscopic localization of the HNK-1 carbohydrate epitope in the anterior segment of Pseudoexfoliation and normal eyes. Curr Eye Res. 1997;16:231–238
  23. Naumann GO, Schlotzer-Schrehardt U, Kuchle M. Pseudoexfoliation for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951–968
  24. Harnisch JP, Barrach HJ, Hassell JR, et al. Identification of a basement membrane proteoglycan in exfoliation material. Graefes Arch Clin Exp Ophthalmol. 1981;215:273–278
  25. Konstas AG, Marshall GE, Lee WR. Iris vasculopathy in exfoliation syndrome An immunocytochemical study. Acta Ophthalmol (Copenh). 1991;69:472–483
  26. Ritch R. Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc. 1994;92:845–944
  27. Prince AM, Ritch R. Clinical signs of the Pseudoexfoliation syndrome. Ophthalmology. 1986;93:803–807
  28. Asano N, Schlotzer-Schrehardt U, Naumann GO. A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology. 1995;102:1279–1290
  29. Schlotzer-Schrehardt U, Naumann GO. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci. 1995;36:1750–1764
  30. Schlotzer-Schrehardt U, Naumann GO. A histopathologic study of zonular instability in pseudoexfoliation syndrome. Am J Ophthalmol. 1994;118:730–743
  31. Schlotzer-Schrehardt U, von der Mark K, Sakai LY, et al. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1997;38:970–984
  32. Schlotzer-Schrehardt U, Küchle M, Naumann GO. Electron microscopic identification of pseudoexfoliative material in extrabulbar tissue. Arch Ophthalmol. 1991;109:565–570
  33. Hammer T, Schlotzer-Schrehardt U, Naumann GO. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. Arch Ophthalmol. 2001;119:1023–1031
  34. Schlotzer-Schrehardt U, Küchle M, Dorfler S, et al. Pseudoexfoliative material in the eyelid skin of pseudoexfoliation suspect patients: a clinico-histopathological correlation. Ger J Ophthalmol. 1993;2:51–60
  35. Repo LP, Suhonen MT, Terasvirta ME, et al. Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Ophthalmology. 1995;102:1199–1205
  36. Mitchell P, Wanf JJ, Smith W. Association of pseudoexfoliation with increased vascular risk. Am Ophthalmol. 1997;124:685–687
  37. Puska P. The amount of lens exfoliation and chamber angle pigmentation in exfoliation syndrome with or with out glaucoma. Acta Ophthalmol Scand. 1995;73:226–232
  38. Sampaolesi R, Zarate J, Croxato O. The chamber angle in exfoliation syndrome. Clinical and pathological findings. Acta Ophthalmol Suppl. 1988;184:48–53
  39. Richardson TM, Epstein DL. Exfoliation glaucoma: a quantitative perfusion and ultrastructural study. Ophthalmology. 1981;88:968–980
  40. Roth AM. Trabecular meshwork in glaucoma associated with the exfoliation syndrome: a scanning electron microscopy study. Glaucoma. 1979;l:35–39
  41. Mapstone R. Pigment release. Br J Ophthalmol. 1981;65:258–263
  42. Johnson DH. Does pigmentation affect the trabecular meshwork?. Arch Ophthalmol. 1989;107:250–254
  43. Bartholomew RS. Pseudoexfoliation and angle closure glaucoma. Glaucoma. 1981;3:213–216
  44. Konstas AG, Stewart WC, Stroman GA, et al. Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open angle glaucoma. Ophthalmic Surg Lasers. 1997;28:111–117
  45. Lindblom B, Thorburn W. Functional damage at diagnosis of primary open angle glaucoma. Acta Ophthalmol (Copenh). 1984;62:223–229
  46. Hagihara O. Clinical features of capsular glaucoma in comparison with primary open angle glaucoma in Japan. Acta Ophthalmol (Copenh). 1992;70:214–219
  47. Hetherington J. Capsular glaucoma: management philosophy. Acta Ophthalmol Suppl. 1988;184:138–140
  48. Brooks AM, Gillies WE. The presentation and prognosis of glaucoma in pseudoexfoliation of the lens capsule. Ophthalmology. 1988;95:271–276
  49. Tarkkanen A, Hietanen J. The impact of exfoliation syndrome on therapeutic efficacy in open angle glaucoma. Curr Opin Ophthalmol. 1995;6(11):10–14
  50. Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open angle glaucoma. Arch Ophthalmol. 1997;115:182–185
  51. Coburn AG, Gross RL. Pseudoexfoliation syndrome. Clin Signs Ophthalmol. 1990;12:2–15
  52. Puska P. Lens opacity in unilateral exfoliation syndrome with or without glaucoma. Acta Ophthalmol (Copenh). 1994;72:290–296
  53. Guzek JP, Holm M, Cotter JB, et al. Risk factors or intra-operative complications in 1000 extracapsular cataract cases. Ophthalmology. 1987;94:461–466
  54. Ritch R. Cataract and exfoliative glaucoma. J Glaucoma. 1998;7:178–181
  55. Hietanen J, Kivela T, Vesti E, et al. Exfoliation syndrome in patients scheduled for cataract surgery. Acta Ophthalmol (Copenh). 1992;70:440–446
  56. Harju M. Intraocular pressure and progression in exfoliative eyes with ocular hypertension or glaucoma. Acta Ophthalmol Scand. 2000;78:699–702
  57. Threlkeld AB, Hertzmark E, Sturm RT, et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open angle glaucoma. Glaucoma. 1996;5:311–316
  58. Ritch R. Initial treatment of exfoliative glaucoma. Glaucoma. 1998;7(2):137–140
  59. Brancato R, Carassa R, Bettin P, et al. Laser treatment of pseudoexfoliation glaucoma. New Trends Ophthalmol. 1993;VIII:229–231
  60. Kajiya S, Hayakawa K, Sawaguchi S. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi. 2000;104:160–164
  61. Popiela G, Muzyka M, Szelepin L, et al. Use of YAG– Selecta laser and argon laser in the treatment of open angle glaucoma. Klin Oczna. 2000;102:129–133
  62. Kajiya S, Hayakawa K, Sawaguchi S. Clinical results of selective laser trabeculoplasty. Jpn J Ophthalmol. 2000;44:574–575
  63. Gracner T. Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol. 2002;12:287–292
  64. Merkur A, Damji KF, Mintsioulis G, et al. Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoliation syndrome. J Cataract Refract Surg. 2001;27:528–532
  65. von der Lippe I, Kuchle M, Naumann GO. Pseudoexfoliation syndrome as a risk factor for acute ciliary block angle closure glaucoma. Acta Ophthalmol (Copenh). 1993;71:277–279
  66. Konstas AG, Lake S, Maltezos AC, et al. Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma. Eye. 2001;15(Pt l):59–62
  67. Nordmann JP, Mertz B, Yannoulis NC, et al. A double masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension 6-month data. Am J Ophthalmol. 2002;133(l):1–10

PII: S1529-1839(04)70052-4

doi:10.1016/S1529-1839(04)70052-4

Optometry - Journal of the American Optometric Association
Volume 75, Issue 4 , Pages 245-250, April 2004

Article Tools